Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis bcl 2 family'

Search results for: 'research area apoptosis bcl 2 family'

Items 1-10 of 21

Page
per page
  1. Danusertib (PHA-739358)
    A4116 Danusertib (PHA-739358)
     2 Citation
    Target: Aurora Kinases
    Summary: Pan-aurora kinase inhibitor
      ≥23.75 mg/mL
  2. NSC 3852
    A4496 NSC 3852
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in EtOH; insoluble in H2O; ≥7.35 mg/mL
  3. TC-A 2317 hydrochloride
    A4489 TC-A 2317 hydrochloride
    Target: Aurora Kinases
    Summary: Aurora kinase A inhibitor,potent and selective
      <39.29 mg/mL
  4. GSK1070916
    A4127 GSK1070916
    Target: Aurora Kinases
    Summary: Aurora B/C inhibitor
      ≥25.4 mg/mL
  5. Chidamide
    B5916 Chidamide
     1 Citation
    Target: HDAC
    Summary: Novel HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥18.55 mg/mL
  6. HPOB
    B4890 HPOB
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor, potent and selective
      ≥31.4 mg/mL
  7. OTX-015
    A3692 OTX-015
     3 Citation
    Target: Bromodomains
    Summary: BRD inhibitor
      ≥24.6 mg/mL
  8. ABC294640
    B1182 ABC294640
    Target: SK
    Summary: Sphingosine kinase 2 inhibitor,selective and competitive
      ≥38.1 mg/mL
  9. Veliparib dihydrochloride
    A3958 Veliparib dihydrochloride
    Target: PARP
    Summary: PARP-1/PARP-2 inhibitor
      ≥31.7 mg/mL
  10. Mocetinostat (MGCD0103, MG0103)
    A4089 Mocetinostat (MGCD0103, MG0103)
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor,isotype-selective and potent
      insoluble in EtOH; insoluble in H2O; ≥19.8 mg/mL

Items 1-10 of 21

Page
per page